AnaptysBio News

AnaptysBio | 8-K: Current report

Jun 13 04:08

AnaptysBio | 8-K: Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update

May 10 04:53

AnaptysBio | DEF 14A: Definitive information statements

Apr 25 04:11

AnaptysBio | DEFA14A: Others

Apr 25 04:10

AnaptysBio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 12 04:43

AnaptysBio | 8-K: Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 12 04:25

AnaptysBio | 8-K: Current report

Jan 5 13:00

AnaptysBio | 8-K: Current report

Nov 28, 2023 05:17

AnaptysBio | 8-K: Anaptys Announces Third Quarter 2023 Financial Results and Provides Business Update

Nov 3, 2023 04:18

AnaptysBio | 8-K: Current report

Oct 26, 2023 04:43

AnaptysBio | 8-K: Current report

Oct 10, 2023 21:01

AnaptysBio | 8-K: Current report

Sep 19, 2023 04:18

AnaptysBio | 8-K: AnaptysBio Announces Second Quarter 2023 Financial Results and Provides Business Update

Aug 8, 2023 04:18

AnaptysBio | 8-K: Current report

Jun 16, 2023 05:15

AnaptysBio | 8-K: AnaptysBio Announces First Quarter 2023 Financial Results and Provides Pipeline Update

May 12, 2023 04:17

AnaptysBio | DEFA14A: Others

Apr 28, 2023 04:12

AnaptysBio | DEF 14A: Definitive proxy statements

Apr 28, 2023 04:05

AnaptysBio | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Apr 15, 2023 04:15

AnaptysBio | 8-K: Current report

Apr 7, 2023 04:18

AnaptysBio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 2, 2023 05:16